The Staphylococcus aureus testing market is likely to cross the estimated market value of US$ 6.9 billion by 2033 while it thrives in the global market at a lower CAGR of 5.3% (2023 to 2033). The market holds a revenue of US$ 4.1 billion in 2023.
The market survey states that the rising number of infections is caused by Staphylococcus aureus. These infections include skin, bacteremia, soft tissue, and infective endocarditis. Furthermore, advanced technology is integrating with diagnostic procedures for staphylococcus aureus as it grows rapidly. The applications of staphylococcus aureus testing in cases of abscesses, furuncles, and cellulitis are rising with the growing awareness around skin care.
The Staphylococcus aureus market outlook shows that the market has been growing steadily since the last forecast cycle. This growth is attributed to the high risks of infected blood fluids and contaminated hands. The increasing sales of staphylococcus aureus testing systems are attributed to the growing geriatric population and skin health awareness. Staphylococcus aureus has long been recognized as an important bacteria that cause different human diseases.
Abscess infections include pocket infections formed around the site of injury that are pus-filled and pocket infections formed around the site of injury that is pus-filled in nature. Cellulitis involves an infection of the underlying layers of the skin. It happens due to some scrape or cut through the skin. The long types of infections are followed by their diagnosis of them. Hence the demand for staphylococcus aureus testing.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 5.3% |
| Market Valuation (2023) | US$ 4.1 billion |
| Market Valuation (2033) | US$ 6.9 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The growing incidence of staph infections is the major factor driving the growth of the global market. An inappropriate sanitary environment is the major cause of the spread of Staph infections. Staphylococcus aureus screening is the mandatory screening test before taking insulin, and growing awareness of bacterial infection across the globe is expected to push the sales of staphylococcus aureus testing systems.
Advanced rapid diagnostic tests availability also boosts the market's growth over the forecast period. However, inadequate reimbursement in developing the region and limited access to regular healthcare may be the restraints for the global market.
Growth Prospects:
Test-based Developments
Market-based Developments
The global market is projected to rise at an impressive CAGR of 5.3% between 2023 and 2033, compared to a 6.7% CAGR registered from 2018 to 2022. The market secured a valuation of US$ 2.8 billion in 2018 and US$ 3.9 billion in 2022.
Principal Consultant
Emerging trends in the market state that the North American market holds a significant market share, with 48.7% of the global market share. The growth factors that work for the development of the market are increasing contaminated infections, pollution and proliferated bacteria counts in food products that lead to higher sensitivity levels in Americans.
Oxford Academic states that the high burden of staphylococcus aureus among Native American individuals on the White Mountain Apache tribal lands is rising. It increases demand for staphylococcus aureus testing in the region.
With a global market share of 33.4%, the European market is growing at an impressive CAGR as the covid-19 has slowed down bacteria contamination.
The new advanced technology, with its highly accurate results, is taking the lead in the market in the region. However, the logistics ban and lockdown have slowed down the market’s pace as there was limited human density in public spaces. Furthermore, the market recovers as the awareness of bacteria-based infections and diseases rises with the changing climate.
Staphylococcus aureus testing startup survey at future marketing insights explains that just like other healthcare/medical/diagnostics market spaces, this market is full of startup ideas that show interest in the rapidly changing diagnosis industry.
The new companies are investing more in the core workings of the staphylococcus aureus testing systems that reduce the testing time and increase the accuracy of the results. As the climate changes and new bacteria-based diseases expand, the different variants of Abscess and Cellulitis infections.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players now add more value to the accuracy of tests and logistics of these Staphylococcus aureus testing systems generally found in diagnostic centers. The new and advanced technology used detects all types of infections. The new startup is shaping the competitive landscape into more edgy and friendly.
Recent mergers and product launches
Abbott Laboratories has introduced its Abbott MS-2 system for staphylococcus aureus testing, which is methicillin-resistant. The agreement between Abbott MS-2 and standard disk diffusion methods procedure has been 94% greater than the antibiotics tested.
Thermofisher Scientific has introduced the Staphylococcal Enterotoxin Reversed Passive Latex Agglutination Kit (SET-RPLA) that detects enterotoxins A, B, C and D in food samples or culture filtrates. Reversed passive latex agglutination (RPLA) enables soluble antigens, such as bacterial toxins, to be detected in an agglutination assay.
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Product, Application, End User, Region |
| Key Companies Profiled | Abbott Laboratories Inc; Siemens Healthcare GmbH; Bio Rad Laboratories Inc; Thermo Fisher Scientific Inc; Roche Diagnostics (H. Hoffman-La Roche Ltd.); STD Rapid Test Kits |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The CAGR of this market is 5.3% through 2033
North America is projected to emerge as a lucrative market.
Limited access to regular healthcare limits the market growth.
North America is likely to generate 48.7% revenue in 2023
Growing awareness of bacterial infection is expected to drive sales.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033
5.3.1. Coagulase Test
5.3.2. Ancillary Tests
5.3.3. Agar-Based Tests
5.3.4. Nucleic Acid Amplification Tests
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Pharmaceutical
6.3.2. Clinical
6.3.3. Food Testing
6.3.4. Other
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Diagnostic Clinics
7.3.3. Food Testing laboratories
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Test Type
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Test Type
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Test Type
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Test Type
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test Type
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Test Type
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Test Type
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Test Type
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Test Type
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Test Type
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Test Type
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Test Type
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Test Type
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Test Type
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Test Type
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Test Type
16.5.2.2. By Application
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Test Type
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Test Type
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Test Type
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Test Type
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Test Type
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Test Type
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Test Type
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Test Type
16.13.2.2. By Application
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Test Type
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Test Type
16.15.2.2. By Application
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Test Type
16.16.2.2. By Application
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Test Type
16.17.2.2. By Application
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Test Type
16.18.2.2. By Application
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Test Type
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Test Type
16.20.2.2. By Application
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Test Type
16.21.2.2. By Application
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Test Type
16.22.2.2. By Application
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Test Type
16.23.2.2. By Application
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Test Type
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Abbott Laboratories Inc
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Siemens Healthcare GmbH
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Bio Rad Laboratories Inc
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Thermo Fisher Scientific Inc
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Roche Diagnostics (H. Hoffman-La Roche Ltd.)
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. STD Rapid Test Kits
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Healthcare
June 2022
REP-GB-10406
328 pages
Explore Healthcare Insights
View Reports
Staphylococcus Aureus Testing Market
